Evaluation on safety and immunogennicity of a combined hepatitis A and B vaccine in children and young adults.
Rong Li
Abstract
Rong Li
Abstract
Objective To evaluate the safety and immunogennicity of a combined hepatitis A and B vaccine,manufactured by Tangshan Yuan Biological Products Co.,Ltd,.Methods137healthy children and127young adults with HbsAg,anti-HBs,anti-HBc and anti-HAV negative selected from Tianyang county of Guangxi Zhuang Autonomous Region were randomly divided into6groups.127children(group AB)and137young adults(group AB)were received5μg/0.5ml and10μg/1.0ml of a home-made combined hepatitis A and B vaccine,respectively,and55children(group B)and55young adults(group B)were received5μg/0.5ml and10μg/1.0ml of hepatitis B vaccine(Beijing Tiantan Biological Products Co.,Ltd,)by0,1,6months schedule,reˉspectively.86children(group A)and137young adults(group A)were received250μ/0.5ml and500μ/1.0ml of inactivated hepatitis A vaccine(Tangshan Yuan Biological Products Co.,Ltd,)by0,6months schedule,reˉspectively The local and systemic side-effects were recorded in the first72hours after each vaccination,and the seroconversion of anti-HAV IgG and anti-HBs were tested at months2and7after the first vaccination.Results The local and systemic side-effects were not observed in all participants within72hours after the first dose of vaccination.Seven months after the first dose of vaccination,the seroconversion rates and GMTs of anti-HAV IgG and anti-HBs were100%,96.8%and29144mIU/mland102mIU/ml in children AB group and100%,98.8%and21891mIU/ml and12mIU/ml in adults AB group,respectively.The seroconversion rates and GMTs of anˉti-HAV IgG and anti-HBs of combined hepatitis A and B vaccine were significantly higher than those of single hepatitis A and hepatitis B vaccines.Conclusion The home-made combined hepatitis A and B vaccine is safe and highly immunogenicity in children and young adults.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the safety and immunogennicity of a combined hepatitis A and B vaccine,manufactured by Tangshan Yuan Biological Products Co.,Ltd,.Methods137healthy children and127young adults with HbsAg,anti-HBs,anti-HBc and anti-HAV negative selected from Tianyang county of Guangxi Zhuang Autonomous Region were randomly divided into6groups.127children(group AB)and137young adults(group AB)were received5μg/0.5ml and10μg/1.0ml of a home-made combined hepatitis A and B vaccine,respectively,and55children(group B)and55young adults(group B)were received5μg/0.5ml and10μg/1.0ml of hepatitis B vaccine(Beijing Tiantan Biological Products Co.,Ltd,)by0,1,6months schedule,reˉspectively.86children(group A)and137young adults(group A)were received250μ/0.5ml and500μ/1.0ml of inactivated hepatitis A vaccine(Tangshan Yuan Biological Products Co.,Ltd,)by0,6months schedule,reˉspectively The local and systemic side-effects were recorded in the first72hours after each vaccination,and the seroconversion of anti-HAV IgG and anti-HBs were tested at months2and7after the first vaccination.Results The local and systemic side-effects were not observed in all participants within72hours after the first dose of vaccination.Seven months after the first dose of vaccination,the seroconversion rates and GMTs of anti-HAV IgG and anti-HBs were100%,96.8%and29144mIU/mland102mIU/ml in children AB group and100%,98.8%and21891mIU/ml and12mIU/ml in adults AB group,respectively.The seroconversion rates and GMTs of anˉti-HAV IgG and anti-HBs of combined hepatitis A and B vaccine were significantly higher than those of single hepatitis A and hepatitis B vaccines.Conclusion The home-made combined hepatitis A and B vaccine is safe and highly immunogenicity in children and young adults.
Key concepts: Seroconversion, Medicine, Vaccination, Hepatitis A vaccine, Hepatitis B, Hepatitis B vaccine, HBsAg, Hepatitis A